8772 RESULTS
COMMENT The German Center for Neurodegenerative Diseases (DZNE) is currently running at a minimal operation mode. Like other institutions, we are thinking about ways to support the battle against COVID-19 by allocating personnel to fill clinical or administrative ...
COMMENT The Alzheimer’s Association's first priority is the health and safety of study participants and study staff, especially vulnerable elders and people with dementia and their families. In this new and uncertain environment, that means reconfiguring ...
COMMENT The evolving COVID-19 pandemic has placed tremendous strain on medical health care systems worldwide as they focus on the ongoing extraordinary medical emergency. Taking this into consideration, UCB has taken measures to protect our patients, trial ...
COMMENT For Alzheimer's disease research, the biggest danger of the COVID-19 (CV) pandemic is not transmission to staff or delay of projects. Little attention has been paid to the possibility this infection might distort the course of AD in patients and ...
COMMENT As you probably are well aware, Spain is now in a complete lockdown. This has affected research centers like ours, Barcelonaβeta Brain Research Center, and the way we work. All participants from our observational studies, like the ALFA+ study, EPAD, ...
COMMENT At Roche and Genentech, our No. 1 priority remains the safety of our patient communities, partners, and employees during this continuing pandemic. In these unprecedented times, we remain committed to people living with Alzheimer’s disease and we are ...
COMMENT For active participants in medication trials, receiving medication or placebo, visits and treatments are continuing. We are not enrolling new participants into these studies at this time. For observational studies (no intervention), we are holding on ...
COMMENT The rise and fall of cortical neurons and the life of an early career researcher during a global pandemic The outbreak of COVID-19, and the lockdown of numerous countries, was the last thing I ever expected to lead to a potentially tragic end of my first ...
COMMENT Since the vast majority of our research participants are older, in their 70s on average, we are especially concerned about their response to a virulent virus like COVID-19. Moreover, we do not consider the observational studies or clinical trials we ...
COMMENT I fear for our centenarians. Today we wrote all centenarians in our study a personal postcard to encourage them to keep strong and stay safe. Centenarians always like it when we visit them, and we won’t be able to do so any longer, for at least a couple ...
COMMENT We have postponed observational study visits but are continuing study infusions for now. Participant attendance is good, but we have seen a mild increase in cancellations because some retirement communities are encouraging residents to stay home, plus ...
COMMENT Until this pandemic has ended, we won’t know its full effects. For example, if clinical research is suspended for weeks or even a few months, there may not be much harm to our current longitudinal studies. Longer suspensions will make it much more ...
COMMENT This pandemic is an unparalleled event, which will have a huge impact on research in the long term. The Netherlands is now in almost complete lockdown. Schools, restaurants, shops are all closed, everything except supermarkets, etc. In the hospitals, ...
COMMENT The COVID-19 pandemic has had a tremendous impact on human subjects research in which I am involved. Our overarching policy is that we need to minimize risk for study participants and research staff. We also are cognizant of resource utilization, e.g., ...
COMMENT In Pittsburgh, we have stopped all in-person research studies, which is essentially all our AD studies. This will obviously slow down progress, but could also lead to complications related to grant project timelines unless the granting agencies allow ...
